Richard Henderson is a British molecular biologist and biophysicist and pioneer in the field ofelectron microscopy ofbiological molecules. Henderson shared theNobel Prize in Chemistry in 2017 withJacques Dubochet andJoachim Frank.[3] "Thanks to his work, we can look at individual atoms of living nature, thanks to cryo-electron microscopes we can see details without destroying samples, and for this he won the Nobel Prize in Chemistry."[4]
Henderson worked on the structure and mechanism ofchymotrypsin for his doctorate under the supervision ofDavid Mervyn Blow at theMRC Laboratory of Molecular Biology.[9] His interest inmembrane proteins led to him working on voltage-gatedsodium channels as a post-doctoral researcher atYale University. Returning to theMRC Laboratory of Molecular Biology in 1975, Henderson worked withNigel Unwin to study the structure of themembrane proteinbacteriorhodopsin byelectron microscopy. A seminal paper inNature by Henderson and Unwin (1975)[10] established a low resolution structural model for bacteriorhodopsin showing the protein to consist of seven transmembrane helices. This paper was important for a number of reasons, not the least of which was that it showed that membrane proteins had well defined structures and that transmembrane alpha-helices could occur. After 1975 Henderson continued to work on the structure ofbacteriorhodopsin withoutUnwin. In 1990 Henderson published an atomic model ofbacteriorhodopsin by electron crystallography in theJournal of Molecular Biology.[11] This model was the second ever atomic model of a membrane protein. The techniques Henderson developed for electron crystallography are still in use.
Together with Chris Tate, Henderson helped develop conformational thermostabilisation: a method that allows any protein to be made more stable while still holding a chosen conformation of interest.[12][failed verification] This method has been critical in crystallising and solving the structures of severalG protein–coupled receptors (GPCRs).[13] With help from the charityLifeArc, Henderson and Tate founded theMRC start-up company, Heptares Therapeutics Ltd (HTL) in 2007.[14] HTL continues to develop new drugs targeting medically important GPCRs linked to a wide range of human diseases.[9]
In the last few years, Henderson has returned to hands-on research focusing on single particle electron microscopy. Having been an early proponent of the idea that single particle electron microscopy is capable of determining atomic resolution models for proteins, explained in a 1995 paper in Quarterly Reviews of Biophysics. Henderson aims to be able to routinely obtain atomic structures without crystals. He has made seminal contributions to many of the approaches used in single particle electron microscopy, including pioneering the development of direct electron detectors that recently allowed single particle cryo-electron microscopy to achieve its goals.[3]
Although Henderson has typically worked independently, he has trained a number of scientists who have gone on to independent research careers. These scientists include:
^Henderson, R; Baldwin, JM; Ceska, TA; Zemlin, F; Beckmann, E; Downing, KH (1990). "Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy".Journal of Molecular Biology.213 (4):899–929.doi:10.1016/S0022-2836(05)80271-2.PMID2359127.